Tim-3 suppresses antitumor response via non-T cell mechanisms involving Tim-3/Tim-3 ligand interactions, such as the interaction between tumor-associated dendritic cell-derived Tim-3 and HMGB1. The gene discussed is HAVCR2; the disease is neoplasm.